TMCLIFE

0.480

-0.005 (-1%)

Change in Principal Officer

TMC LIFE SCIENCES BERHAD

Date of change 10 Feb 2025
Name DATO' DR AHMAD ADZUAN BIN ABDUL RAHMAN
Age 48
Gender Male
Nationality Malaysia
Type of change Appointment
Designation Group Chief Executive Officer

Qualifications

No
Qualifications
Major/Field of Study
Institute/University
Additional Information
Others
Executive Education Program in Mergers & Acquisitions (M&A)
Imperial College Business School, United Kingdom
Masters
Master of Business Administration
International Institute for Management Development, Switzerland
Degree
Bachelor of Medicine and Surgery; Bachelor of Obstetrics
Queen's University Belfast, United Kingdom
  
Working experience and occupation
Novotec Group Pte. Ltd.
July 2023 to November 2024
Founding member and advisor

IDS Medical Systems (idsMED)
October 2020 to June 2023
Regional Managing Director & Executive Vice President (idsMED Group)

September 2018 to September 2020
Managing Director (Malaysia) & Senior Vice President (idsMED Group); later Managing Director (Malaysia) & Executive Vice President in September 2019

Gleneagles Kuala Lumpur, Malaysia
March 2015 to August 2018 
Chief Executive Officer

Parkway East Hospital, Singapore
January 2014 to February 2015
Chief Executive Officer

Parkway Laboratory Services, Singapore
June 2012 to December 2013
Chief Operation Officer

Eli Lilly & Co., Hong Kong
January 2011 to June 2012
Asia Mid-Size Medical Advisor, Diabetes and Endocrinology

International Consulting Project - Pan-European, South Africa
2010

National Health Service, South Wales, United Kingdom
2006 to 2009
Doctor in Specialist Training - Diabetes & Endocrinology

National Health Service, East Yorkshire, United Kingdom
2003 to 2006
Doctor in Rotational Training - Internal Medicine 

National Health Service, Country Antrim, Northern Ireland, United Kingdom
2002 to 2003
Junior Doctor - General Surgery and General Medicine
Directorships in public companies and listed issuers (if any)
Nil
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Nil


Remarks :
Dato' Dr. Ahmad Adzuan bin Abdul Rahman was appointed as the Group Chief Executive Officer of TMC Life Sciences Berhad and Regional Senior Director of Thomson Medical Group on 10 February 2025.


Announcement Info

Company Name TMC LIFE SCIENCES BERHAD
Stock Name TMCLIFE
Date Announced 10 Feb 2025
Category Change in Principal Officer
Reference Number C04-20012025-00003